Haleon plc
Every calculator, already run for HLN
Open the full toolkit →You have the numbers on HLN. Get the argument.
A written report on which of these readings actually decide the outcome for Haleon plc, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
5 analysts covering HLNAnalyst Price Target Disagreement for Haleon plc
Wall Street's bull case implies +59% from the current price; the bear case implies +15%. A 43% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for HLN
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Pa…
HLN — frequently asked
Is HLN a buy right now?
Wall Street's consensus rating on Haleon plc is Buy across 5 analysts, with a mean price target of $11.59 (+33% vs. the current $8.69). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is HLN overvalued?
HLN trades at 17.7x trailing earnings, against a DCF fair value of $16 per share. The current price implies -1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
What is the analyst price target disagreement for Haleon plc?
Analysts covering Haleon plc (HLN) range from a bear-case target of $10.00 to a bull-case high of $13.77, with a mean consensus target of $11.59 across 5 analysts. The spread of $3.77 (43% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Haleon plc against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Haleon plc
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full HLN research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Haleon plc, in minutes. 3 free reports included with every account — no credit card required.